MAPK3 and Miyoshi myopathy: We followed to confirm the involvement of FHND004 targeting PBK in the MAPK pathway by detecting the expression of ERK1/2 and p-ERK1/2 in PBK-WT, PBK-OE MM cells with/without the treatment of FHND004.